Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceutical products in India and internationally. The company offers pharmaceutical products across various therapeutic areas, including antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpaste.
Balaxi Pharmaceuticals Limited (BALAXI) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The BALAXI share price is ₹22.34 (+2.06% today), with a market capitalisation of ₹1B and a price-to-earnings (P/E) ratio of 49.6. MarketRipple tracks the BALAXI investment thesis, the ripple-chain impact of market events on Balaxi Pharmaceuticals Limited, and the Healthcare sector outlook.
Open
₹22.40
High
₹22.40
Low
₹21.00
Prev. Close
₹21.89
52W High
₹42.74
52W Low
₹15.20
Day range
₹21.00–₹22.40
52-week range
₹15.20–₹42.74
Volume
11K
P/E
49.6
ROE
0.6%
D/E
0.23
Margin
0.9%
Balaxi Pharmaceuticals Limited (NSE: BALAXI) is currently trading at ₹22.34 (+2.06%).
Balaxi Pharmaceuticals Limited's market capitalization is ₹1B.
Balaxi Pharmaceuticals Limited's price-to-earnings (P/E) ratio is 49.6.
Balaxi Pharmaceuticals Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).